The Athlete Blood Passport is the most recent tool adopted by anti-doping authorities to detect athletes using performance-enhancing drugs such as recombinant human erythropoietin (rhEPO). This strategy relies on detecting abnormal variations in haematological variables caused by doping, against a background of biological and analytical variability. Ten subjects were given twice weekly intravenous injections of rhEPO for up to 12 weeks. Full blood counts were measured using a Sysmex XE-2100 automated haematology analyser, and total haemoglobin mass via a carbon monoxide rebreathing test. The sensitivity of the passport to flag abnormal deviations in blood values was evaluated using dedicated Athlete Blood Passport software. Our treatment regimen elicited a 10% increase in total haemoglobin mass equivalent to approximately two bags of reinfused blood. The passport software did not flag any subjects as being suspicious of doping whilst they were receiving rhEPO. We conclude that it is possible for athletes to use rhEPO without eliciting abnormal changes in the blood variables currently monitored by the Athlete Blood Passport.

The purpose of this investigation was to examine the strength, power, and anthropometric contributors to vertical jump performances that are considered specific to volleyball success, including countermovement vertical jump (CMVJ) and spike jump (SPJ), by examining changes across 12 months in elite volleyball players. Anthropometry (height, mass, summation Sigma 7 skinfolds), vertical jump ability (CMVJ, SPJ, and depth jumps from 35 cm), kinetic and kinematic data from an unloaded and loaded (body mass + 50%) jump squat were assessed before and after 12 months of training in 20 elite male volleyball players. To examine the association between the change in each of the strength, power, and anthropometric variables with the changes in CMVJ and SPJ, a correlation analysis of the percent change of each variable with the percent change in CMVJ and SPJ was performed. A significant correlation (r = 0.47; p = 0.04) was observed between changes in CMVJ and SPJ. Significant (p = 0.006-0.02) improvements in CMVJ were associated with increased peak force in the unloaded (r = 0.61) and loaded jump squat (r = 0.59) and greater relative power and peak velocity in the loaded jump squat (r = 0.49 and 0.51, respectively). The significant increase in CMVJ was strongly associated (r = 0.865; p < 0.001) with an improved depth-jump ability. Significant (p = 0.003-0.03) increases in SPJ were related to increases in relative power (r = 0.64), peak force (r = 0.46), and peak velocity (r = 0.49) in the loaded jump and improved depth-jumping ability (r = 0.591). This study demonstrates that, in an elite population of volleyball players, stretch-shortening cycle performance and the ability to tolerate high stretch loads, as in the depth jump, are critical to improving jumping performance.

We compared changes in performance and total haemoglobin mass (tHb) of elite swimmers in the weeks following either Classic or Live High:Train Low (LHTL) altitude training. Twenty-six elite swimmers (15 male, 11 female, 21.4 ± 2.7 years; mean ± SD) were divided into two groups for 3 weeks of either Classic or LHTL altitude training. Swimming performances over 100 or 200 m were assessed before altitude, then 1, 7, 14 and 28 days after returning to sea-level. Total haemoglobin mass was measured twice before altitude, then 1 and 14 days after return to sea-level. Changes in swimming performance in the first week after Classic and LHTL were compared against those of Race Control (n = 11), a group of elite swimmers who did not complete altitude training. In addition, a season-long comparison of swimming performance between altitude and non-altitude groups was undertaken to compare the progression of performances over the course of a competitive season. Regardless of altitude training modality, swimming performances were substantially slower 1 day (Classic 1.4 ± 1.3% and LHTL 1.6 ± 1.6%; mean ± 90% confidence limits) and 7 days (0.9 ± 1.0% and 1.9 ± 1.1%) after altitude compared to Race Control. In both groups, performances 14 and 28 days after altitude were not different from pre-altitude. The season-long comparison indicated that no clear advantage was obtained by swimmers who completed altitude training. Both Classic and LHTL elicited ~4% increases in tHb. Although altitude training induced erythropoeisis, this physiological adaptation did not transfer directly into improved competitive performance in elite swimmers.